Lumosa Therapeutics Co LtdTPEX: 6535

Important resolutions of LUMOSA's 2022 Annual Shareholders' Meeting

· Issued by Lumosa Therapeutics Co Ltd
Close
Today's Information

Provided by: LUMOSA THERAPEUTICS CO., LTD.
SEQ_NO 1 Date of announcement 2022/05/24 Time of announcement 16:55:52
Subject
 Important resolutions of LUMOSA's 2022
Annual Shareholders' Meeting
Date of events 2022/05/24 To which item it meets paragraph 18
Statement
1.Date of the shareholders' meeting:2022/05/24
2.Important resolutions  I.Profit distribution/deficit compensation:
 Adoption of the Proposal for 2021 Deficit Compensation.
3.Important resolutions II.Amendments of the company charter:
Approval of the issuance of amendments to the Articles of Incorporation
4.Important resolutions III.Business report and financial statements:
Adoption of the 2021 Business Report and Financial Statements.
5.Important resolutions IV.Election for directors and supervisors:NA
6.Important resolutions V.Other matters:
(1)Approval of the issuance of amendment to the Procedures for Acquisition or
Disposal of Assets.
(2)Approval of the issuance of common shares for cash in private placement.
(3)Approval of the issuance of release the prohibition on directors or its
representatives from participation in competitive business.
7.Any other matters that need to be specified:None.

Earlier from Lumosa Therapeutics

All Lumosa Therapeutics news releases